The role of apoptosis in induction ocular changes in patients with cystic fibrosis;Rola apoptozy w indukowaniu zmian ocznych u pacjentów z mukowiscydoza

Klinika Oczna

Volumn 109, Issue 1-3, 2007, Pages 22-24

  Mrugacz, Małgorzata ^a,b   Zelazowska Rutkowska, Beata ^a   Bakunowicz Łazarczyk, Alina ^a   Wysocka, Jolanta ^a   Kaczmarski, Maciej ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b Klinika Okulistyki Dzieciecej   (Poland)

Author keywords

Apoptosis; Cystic fibrosis; sFas

Indexed keywords

EID: 34447528725     PISSN: 00232157     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Klupa T.: Apoptoza - od teorii do praktyki. Przeglad Lekarski, 1998, 55, 528-531.
2. Durieu I., Amsellem C., Paulin C., Chambe M., Bienvenu J., Bellon G, Pacheco Y.: Fas and Fas ligand expression in cystic fibrosis airway epithelium. Thorax, 1998, 54, 1093-1098.
3. Mrugacz M., Minarowska A., Bakunowicz-Łazarczyk A., Żywalewska N.: Zespół suchego oka u dzieci z mukowiscydoza. Med. Wieku Rozwoj., 2004, 8, 865-870.
4. Mrugacz M., Minarowska A.: Objawy oczne wzłóknieniu torbielowatym. Klin. Oczna, 2002, 104, 418-20.
5. Tsubota K., Fujita H., Tadano K., Onoda N., Tsuzaka K., Takeuchi T.: Abnormal expression and function of Fas ligand of lacrimal glands and peripheral blood in Sjogren's syndrome patients with enlarged exocrine glands. Clin. Exp. Immunol., 2002, 129, 177-182.
6. Strong B., Parley W., Stern M.E., Pflugfelder S.C.: Topical cyclosporine inhibits conjunctival epithelial cells apoptosis in experimental murine keratoconjunctivitis sicca. Cornea, 2005, 24, 80-5.
7. Brignole F., De Saint- Jean M., Goldshild M., Becquet F., Goguel A., Baudouin C.: Expression of Fas-Fas ligand antigens and apoptotic marker AP02.7 by the human conjunctival epithelium. Positive correlation with class II HLA DR expression in inflammatory ocular surface disorders. Exp. Eye Res., 1998, 67, 687-697.
8. Shakibaei M., Schultze-Tanzil G., Takada Y.: Redox regulation of apoptosis by members of the superfamily. Antioxid Redox Signal, 2005, 7, 482-496.
9. Limkermann A., Qian J., Lettau M.: Considering Fas ligand as a target therapy. Expert Opin. Ther. Target, 2005, 9, 119-34.
10. Mahovic D., Petravic D., petelin Z., Zurak N., Horvat G., Hajnsek S.: Level of sFas/APO 1 in serum and cerebrospinal fluid in multiple sclerosis. Clin. Neurol. Neuroserg., 2004, 106, 230-232.
11. Tuominen I., Vesaluoma M., Teppo AM., Gronhagen-Riska C., Tervo T.: Soluble Fas and Fas ligand in human tear fluid after photorefractive keratectomy. Br. J. Ophthalmol., 1999, 83, 1360-1363.
12. Blancheteau V., Charron D., Mooney N.: HLA class II signals sensitize B lymphocytes to apoptosis via Fas/CD95 by increasing FADD recruitment to activated Fas and activation of caspases. Hum. Immunol., 2002, 63, 375-383.
13. Gottlieb RA, Dosanjh A.: Mutant cystic fibrosis transmembrane conductance regulator inhibits acidification and apoptosis in C127 cells: possible relevance to cystic fibrosis. Proc. Natl. Acad. Sci. USA, 1996, 93, 3587-3591.
14. Maiuri L, Raia V, De Marco G.: DNA fragmentation is a feature of cystic fibrosis epithelial cells: a disease with inappropriate apoptosis?. FEBS, 1997, 408, 225-231.
15. Griffith TS, Brunner T, Flechter SM.: Fas ligand-induced apoptosis as a mechanism of immune tolerance. Science, 1995, 270, 1189-1192.
16. Brignole F., De Saint-Jean M., Goldshild M., Becquet F., Goguel A., Baudouin C.: Expression of Fas-Fas ligand antigens and apoptotic marker AP02.7 by the human conjunctival epithelium. Positive correlation with class II HLA DR expression in inflammatory ocular surface disorders. Exp. Eye Res., 1998, 67, 687-697.
17. De Saint Jean M, Brignole F, Feldmann G, Goguel A, Baudouin C.: Interferon-γ induces apoptosis and expression of inflammation-related proteins in Chang conjunctival clls. Invest. Ophthalmol. Vis. Sci., 1999, 40, 2199-2212.
18. Yeh S., Song X.J., Farley W., Li D.-O., Stern M.E., Pflugfelder S.C.: Apoptosis of ocular surface cells in experimentally induced dry eye. Invest. Ophthalmol. Vis. Sci., 2003, 44, 124-129.
19. Tsubota K., Fujita H., Tadano K., Onoda N., Tsuzaka K., Takeuchi T.: Abnormal expression and function of Fas ligand of lacrimal glands and peripheral blood in Sjogren's syndrome patients with enlarged exocrine glands. Clin. Exp. Immunol., 2002, 129, 177-182.